awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35545472-F660F477-8C4E-48DC-B0DD-5FCF98FB77F1
Q35545472-F660F477-8C4E-48DC-B0DD-5FCF98FB77F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35545472-F660F477-8C4E-48DC-B0DD-5FCF98FB77F1
Efficacy and safety of chemotherapy or tyrosine kinase inhibitors combined with bevacizumab versus chemotherapy or tyrosine kinase inhibitors alone in the treatment of non-small cell lung cancer: a systematic review and meta-analysis.
P2860
Q35545472-F660F477-8C4E-48DC-B0DD-5FCF98FB77F1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35545472-F660F477-8C4E-48DC-B0DD-5FCF98FB77F1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6cecb22cbe33501828a26db83341b1b2065a146f
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.